The use of cannabis to treat asthma isn’t entirely new, and the bronchodilating abilities of THC have been investigated.1 CBD is a new area of research, and a recent review of preclinical data suggests that CBD could be useful in treating inflammatory lung diseases by reducing the protein concentration and production of inflammation-inducing cytokines and chemokines.2 A preclinical study in Brazil supports the use of CBD to modulate the inflammatory response in asthma.3
- A. Calignano et al., “Bidirectional Control of Airway Responsiveness by Endogenous Cannabinoids,” Nature 408, no. 6808 (2000): 96–101.
- Sumner Burstein, “Cannabidiol (CBD) and Its Analogs: a Review of Their Effects on Inflammation,” Bioorganic & Medicinal Chemistry 23, no. 7 (2015): 1377–85, doi:10.1016/j.bmc.2015.01.059.
- Francieli Vuolo et al., “Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma,” Mediators of Inflammation 2015, (May 2015). doi:10.1155/2015/538670.